Chief Medical Officer

Jan Schellens is Co-founder of Modra Pharmaceuticals and remains involved with the company as an advisor on medical and regulatory strategies. He was a medical oncologist, clinical pharmacologist, and head of the Department of Clinical Pharmacology (GCP-licensed) of the NKI-AvL, and Professor of Clinical Pharmacology at Utrecht University in the Netherlands.

Jan has authored more than 750 scientific publications. He has over 20 years of experience in clinical drug research and over 15 years of experience in drug regulation as member of the Dutch Medicines Evaluation Board (CBG-MEB). He was member of the Scientific Advisory Group Oncology to the European Medicines Agency for 12 years, and was Chair between 2006 and 2012. Jan is an advisor to many pharmaceutical companies including AstraZeneca, Astex, Merck, Pfizer, Roche, Eisai and Clovis Pharma.

Jan received his Bachelor of Science in Chemistry, his Doctor of Medicine and his Doctor of Philosophy from the State University in Utrecht.